Journal of labelled compounds and radiopharmaceuticals p. 1095 - 1105 (2000)
Update date:2022-08-03
Topics: Animal Studies Elimination Regulatory Approval Toxicity Studies Pharmacokinetics and Pharmacodynamics Metabolism Human Studies
McEvoy Egan
Dean
Marks
Song, Zhiguo
Melillo
A carbon-14 labeled version of the ascomycin analog 1, a potential new immunosuppressant agent, was synthesized for utilization in animal and human drug metabolism studies. In order to place the carbon-14 label at a metabolically stable position, it was n
View MoreWuhan Sunrise Pharmaceutical Technology Co., Ltd
Contact:+86-27-83314682
Address:Room 340, New material Industrial base No.17, Gu Tian Five Lu , Qiaokou District, Wuhan , China
Chengdu Aslee Biopharmaceuticals, Inc
Contact:18608018419
Address:Chengdu Aslee Biopharmaceuticals, Inc
website:http://www.hope-chem.com
Contact:86-21-58090396-805
Address:Floor 4, Building 5, No.588 Tianxiong Road, Zhoupu International Medical Zone, ShangHai, China
Shanghai KFSL Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-39971718
Address:859 jiadingchengliu shanghai
Contact:86-574-26865651
Address:529 YuanBaoShan Road, Beilun District
Doi:10.1016/j.bmc.2012.05.022
(2012)Doi:10.1021/ja001597l
(2000)Doi:10.1002/ejoc.202000834
(2020)Doi:10.1055/s-1991-26449
(1991)Doi:10.1021/jm00350a002
(1982)Doi:10.1021/jo01374a014
(1954)
